Improving Compliance With Medical Testing Guidelines

Study summary

The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedColor-coded materials and Academic detailing

Plus 2 other study approaches.

Who it may be forBreast Cancer · Cervical Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 26, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Beth Israel Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: Beth Israel Medical Center
Interventions being studied: Other: Color-coded materials; Other: Academic detailing; Other: Standard support; Other: No academic detailing

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients: healthy men and women ages 30-89 seeing their primary care provider for routine visit
Providers: non-pediatric primary care physicians from Mount Sinai Beth Israel or St. Luke's-Roosevelt associated practices

Reasons someone may not be able to joinExclusion criteria

Patient life expectancy of less than 1 year in primary care provider's judgment
Inability to read and understand English
Transgender status

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mount Sinai Beth IsraelNew York, New York
St. Luke's-RooseveltNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 26, 2019. Always confirm current availability with the study team.

View original record ↗